SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

SMTL ID : 8uo9.1

Structure of synaptic vesicle protein 2A in complex with a nanobody

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY 3.30 Å
Oligo State
hetero-1-1-mer
Ligands
1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x X49: (4S)-1-{[(4S)-2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl}-4-(4,4,4-trifluorobutyl)pyrrolidin-2-one(Non-covalent)
1 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
1 x PS1: 1,2-DIDECANOYL-SN-GLYCERO-3-[PHOSPHO-L-SERINE](Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Mittal, A. et al., Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsants. Nat.Struct.Mol.Biol. (2024)
Release Date
2024-05-22
Peptides
Synaptic vesicle glycoprotein 2A: A
Nanobody: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
Membrane
We predict this structure to be a membrane protein.

Synaptic vesicle glycoprotein 2A

Nanobody

Related Entries With Identical Sequence

8uoa.1